S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Fed's Shocking New Plan to Control Your Money (Ad)
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Fed's Shocking New Plan to Control Your Money (Ad)
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Fed's Shocking New Plan to Control Your Money (Ad)
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Fed's Shocking New Plan to Control Your Money (Ad)
Closing prices for crude oil, gold and other commodities
Dividend King Genuine Parts Company Upgraded On Profit Guidance
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
11 Best Consumer Discretionary Stocks of 2023
The Bottom Is In For Accenture
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
14 Best Consumer Staples Dividend Stocks
10 Best Consumer Discretionary ETFs
NYSE:EHC

Encompass Health - EHC Competitors

$52.37
+0.61 (+1.18%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$51.30
$52.40
50-Day Range
$51.55
$63.21
52-Week Range
$44.33
$74.61
Volume
443,557 shs
Average Volume
1.04 million shs
Market Capitalization
$5.22 billion
P/E Ratio
19.40
Dividend Yield
1.15%
Price Target
$69.00

EHC vs. SEM, GMED, LHCG, RXDX, IONS, LNTH, SHC, ENSG, ROIV, and MEDP

Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Globus Medical (GMED), LHC Group (LHCG), Prometheus Biosciences (RXDX), Ionis Pharmaceuticals (IONS), Lantheus (LNTH), Sotera Health (SHC), The Ensign Group (ENSG), Roivant Sciences (ROIV), and Medpace (MEDP). These companies are all part of the "medical" sector.

Encompass Health vs.

Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk.

Select Medical presently has a consensus price target of $33.75, indicating a potential upside of 36.97%. Encompass Health has a consensus price target of $69.00, indicating a potential upside of 31.75%. Given Select Medical's higher possible upside, equities analysts clearly believe Select Medical is more favorable than Encompass Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Encompass Health
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.00

In the previous week, Encompass Health had 2 more articles in the media than Select Medical. MarketBeat recorded 5 mentions for Encompass Health and 3 mentions for Select Medical. Encompass Health's average media sentiment score of 0.90 beat Select Medical's score of 0.69 indicating that Encompass Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Select Medical
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Encompass Health
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Encompass Health received 152 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 72.27% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Select MedicalOutperform Votes
317
57.85%
Underperform Votes
231
42.15%
Encompass HealthOutperform Votes
469
72.27%
Underperform Votes
180
27.73%

78.8% of Select Medical shares are held by institutional investors. Comparatively, 96.1% of Encompass Health shares are held by institutional investors. 19.1% of Select Medical shares are held by insiders. Comparatively, 2.7% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Encompass Health has a net margin of 5.54% compared to Select Medical's net margin of 2.51%. Encompass Health's return on equity of 16.15% beat Select Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Select Medical 2.51% 11.86% 2.10%
Encompass Health 5.54% 16.15% 5.45%

Encompass Health has lower revenue, but higher earnings than Select Medical. Encompass Health is trading at a lower price-to-earnings ratio than Select Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Select Medical$6.33 billion0.49$158.99 million$1.2320.03
Encompass Health$4.35 billion1.20$271 million$2.7019.40

Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 2.0%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 1.1%. Select Medical pays out 40.7% of its earnings in the form of a dividend. Encompass Health pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Select Medical has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.

Summary

Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EHC vs. The Competition

MetricEncompass HealthHospitals IndustryMedical SectorNYSE Exchange
Market Cap$5.22B$1.64B$4.33B$14.08B
Dividend Yield1.13%2.52%2.39%3.85%
P/E Ratio19.40845.52107.4920.09
Price / Sales1.2034.313,459.4610.38
Price / Cash9.8511.3227.2724.57
Price / Book2.862.054.476.79
Net Income$271M$82.30M$114.81M$870.19M
7 Day Performance1.59%0.61%-0.80%0.71%
1 Month Performance-13.04%-10.59%-6.59%-7.20%
1 Year Performance-23.02%-29.32%-16.48%-15.19%

Encompass Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SEM
Select Medical
3.5368 of 5 stars
$24.90
-2.9%
$33.75
+35.5%
+0.7%$3.17B$6.33B20.2453,800Positive News
GMED
Globus Medical
3.0735 of 5 stars
$52.26
-1.7%
$70.91
+35.7%
-23.3%$5.24B$759.12M28.102,600Analyst Downgrade
Positive News
LHCG
LHC Group
1.4123 of 5 stars
$169.81
+0.5%
$170.00
+0.1%
+8.3%$5.27B$2.22B82.8330,000High Trading Volume
RXDX
Prometheus Biosciences
1.737 of 5 stars
$106.47
-5.6%
$136.70
+28.4%
+171.2%$5.06B$6.81M-30.5972
IONS
Ionis Pharmaceuticals
2.4221 of 5 stars
$35.29
-0.9%
$45.17
+28.0%
-8.0%$5.04B$587M-18.57660Analyst Report
News Coverage
LNTH
Lantheus
2.5945 of 5 stars
$80.47
-2.9%
$107.33
+33.4%
+59.9%$5.43B$935.06M236.68612
SHC
Sotera Health
1.8096 of 5 stars
$17.73
-1.3%
$16.83
-5.1%
-19.3%$5.01B$1.00B-21.363,000
ENSG
The Ensign Group
2.9013 of 5 stars
$89.32
-2.7%
$103.60
+16.0%
+6.2%$4.98B$3.03B22.6129,900Dividend Announcement
Analyst Upgrade
ROIV
Roivant Sciences
2.1851 of 5 stars
$7.27
-4.8%
$12.50
+71.9%
+35.4%$5.51B$55.29M-4.08620Insider Selling
MEDP
Medpace
2.9853 of 5 stars
$178.78
-3.1%
$235.50
+31.7%
+13.4%$5.55B$1.46B24.425,200Analyst Downgrade
News Coverage
This page (NYSE:EHC) was last updated on 3/25/2023 by MarketBeat.com Staff